Literature DB >> 33553891

pH-Responsive Cellulose-Based Microspheres Designed as an Effective Oral Delivery System for Insulin.

Yaqi Gong1, Shabbir Mohd1, Simei Wu1, Shilin Liu2,3, Ying Pei3, Xiaogang Luo1,3.   

Abstract

Functional modified cellulose microsphere (CMs) materials exhibit great application potential in drug various fields. Here, we designed pH-responsive carboxylated cellulose microspheres (CCMs) by the citric/hydrochloric acid hydrolysis method to enhance oral bioavailability of insulin by a green route. The CMs were high purity cellulose that dissolved and regenerated from a green solvent by the green sol-gel method. The prepared microspheres were characterized by spectroscopic techniques, such as field emission scanning electron microscopy (FE-SEM), Fourier transform infrared spectrum (FT-IR), X-ray diffraction (XPS), etc. The spherical porous structure and carboxylation of cellulose were confirmed by FESEM and FT-IR, respectively. Insulin was loaded into the CCMs by electrostatic interactions, and the insulin release was controlled through ionization of carboxyl groups and proton balance. In vitro insulin release profiles demonstrated the suppression of insulin release in artificial gastric fluid (AGF), while a significant increase at artificial intestinal fluid (AIF) was observed. The insulin release profile was fitted in Korsmeyer-Peppas kinetic model, and insulin release was governed by the Fickian diffusion mechanism. The stability of the secondary structure of insulin was studied by dichroism circular. Excellent biocompatibility and no cytotoxicity of designed CCMs cast them as a potential oral insulin carrier.
© 2021 The Authors. Published by American Chemical Society.

Entities:  

Year:  2021        PMID: 33553891      PMCID: PMC7860066          DOI: 10.1021/acsomega.0c04946

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Oral administration of drugs is desirable due to the convenience and increased compliance to patients, especially for chronic diseases, such as diabetes,[1] that require frequent administration. Although, enzyme degradation and hydrolysis in the gastrointestinal tract could limit the effectiveness of insulin.[2] Insulin is a hormone, which regulates blood sugar, advised to diabetic patients, and it also undergoes degradation in the presence of gastric enzymes and acids due to destruction of disulfide bonds.[3−5] pH-responsive carriers offer excellent potential as oral therapeutic systems by enhancing the stability of insulin delivery in stomach and achieving controlled release in intestines. This motivates the development of an oral insulin transport carrier to improve its bioavailability, and various studies have been reported.[6−12] Considering the advantages of natural materials, researchers are looking for nontoxic, biocompatible, biorenewable, and low-cost natural materials to replace synthetics. Several naturally derived polymers have been investigated to design pH-responsive insulin carriers owing to their renewable and biocompatible nature.[13,14] Some researchers designed natural polymer-based insulin delivery systems, but most of them utilized toxic reagents in complex preparation methods.[13,15] Cellulose microsoheres (CMs), has been widely explored for its high porosity, hydrophilicity, biocompatibility, and great modification potential.[16] Therefore, cellulose-based microspheres can reasonably be used as a drug carrier. Although the microsphere system is not as convenient as the nanometer system, still they have the advantages of controlling the amount of insulin released in the stomach to protect insulin from the inhospitable environment of the stomach.[17] Microspheres can reduce the dosing frequency and thereby improve patient compliance. CMs are easy to prepare by the sol–gel method from the green solvent (sodium hydroxide/urea aqueous solution). The high porosity, appropriate specific surface area, and hydrophilicity of cellulose-based microspheres play key roles in insulin loading and controlled release ability.[16] In addition, in accordance to the structure and physicochemical properties of the insulin, the interfacial microstructure (such as pore size and particle size) of cellulose-based microspheres can be controlled to design high-performance oral insulin carriers to improve the bioavailability of insulin.[18] Since cellulose is nondigestible and nondegradable in the human body, cellulose-based microsphere-loaded insulin can be released continuously in the body without affecting the carrier’s structure. Insulin is a proteinaceous drug with amino and carboxyl groups in its structure with an isoelectric point (pI) of 5.5–6.4.[19] The pIof cellulose was 3.0. The carboxylation of CMs introduces anionic functional groups that reduced the pI of carboxylated cellulose microspheres (CCMs), which helps to bind with the insulin drug via electrostatic interactions. The citric/hydrochloric acid hydrolysis method is a green chemistry approach to fabricate CCMs, where hydronium ions (H3O+) from HCl dissociation hydrolyze the amorphous domains of CMs and catalyze the esterification of hydroxyl groups on the exposed CMs simultaneously.[20] Optimal pH environments promote insulin loading and release via electrostatic interactions between insulin and CCMs. In order to design a new oral insulin carrier by a simple green route, pH-responsive CCMs were prepared though the citric/hydrochloric acid hydrolysis method to control oral insulin delivery. CCMs’ morphology, insulin loading and controlled release profiles, and the mechanism involving the interactions between insulin and CCMs were investigated. The circular dichroism (CD) analysis of native insulin and released insulin and in vitro cytotoxicity of CMs and CCMs were also evaluated to establish the effectiveness of designed materials in drug delivery systems.

Results and Discussion

Morphology and Structure Characterization

FE-SEM images of CMs, CCMs, and insulinCCMs are shown in Figure . All the samples exhibited good spherical shape and a highly crowded porous three-dimensional (3D) structure. The porous structure was regulated by the gelation and regeneration processes of cellulose solution when treated with a large volume of nonsolvent and a relatively high temperature; the phase separation happened during the process, and the solvent-rich regions in cellulose solution contributed to the pore formation.[21] The porous structure of CMs is conducive to the chemical reaction and drug loading, which made cellulose-based microspheres ideal candidates as insulin carriers. Generally, the presence of pores facilitates the penetration of water/insulin solution into CCMs, consequently benefits the diffusion and absorbency of insulin. Compared with CMs (Figure b), the pores of CCMs (Figure e) increased slightly. It may be due to the electrostatic repulsion between carboxyl groups of CCMs resulted in a larger pore of CCMs than that of CMs. InsulinCCMs exhibited smaller pores than CMs and CCMs(Figure h). The reason could be that positively charged insulin was loaded into negatively charged CCMs by electrostatic interaction to occupy the space of pore of CCMs at pH = 4 PBS. The element content of the surfaces of CMs, CCMs, and insulinCCMs were measured by energy dispersive X-ray spectroscopy (EDS) patterns (Figure c,f,i). Compared to CMs and CCMs, the presence of sulfur element on the surface of insulinCCMs indicated that insulin was loaded into the CCMs.
Figure 1

FESEM images of CMs (a, b), CCMs (d, e), and insulin-CCMs (g, h); EDS patterns of CMs (c), CCMs (f), and insulin-CCMs (i).

FESEM images of CMs (a, b), CCMs (d, e), and insulin-CCMs (g, h); EDS patterns of CMs (c), CCMs (f), and insulin-CCMs (i). Correlation between the chemical structures of CMs, CCMs, and insulinCCMs was studied with FT-IR spectra (Figure a). There was a broad peak between 3000–3300 cm–1, which could be attributed to −OH groups of cellulose.[22] Compared with CMs, a new carbonyl peak was observed at 1730 cm–1, indicating the presence of carboxyl groups (−COOH) on CCMs. This could be caused by the hydronium ions (H3O+) from HCl catalyzed during the esterification of hydroxyl groups on the exposed CM chains with carboxyl groups of C6H8O7.[20] The graft yield and grafting efficiency of CCMs were 12.2 and 4.2%, respectively. The results indicated that the carboxyl groups of citric acid were successfully grafted into CMs via the esterification reaction.
Figure 2

FT-IR spectra of CMs, CCMs, and insulin–CCMs (a); TGA and DTGA curves of CMs and CCMs (b); zeta potential of CCMs (c).

FT-IR spectra of CMs, CCMs, and insulinCCMs (a); TGA and DTGA curves of CMs and CCMs (b); zeta potential of CCMs (c). Generally, drug carriers require high-temperature treatment before using, so it was necessary to evaluate the thermal stability of CMs and CCMs.[23] The thermogravimetric analysis (TGA) and differential thermogravimetric analysis (DTGA) for CMs and CCMs are displayed in Figure b. Interestingly, CCMs exhibited a slightly lower onset degradation temperature (111.28 °C) than that of CMs (124.2 °C). This might be a result of the insertion of carboxyl group that disrupted the hydrogen bonding of CMs.[20] Moreover, the small weight loss at the low-temperature range was due to the evaporation of absorbed water, whereas the two other weight losses were due to pyrolysis of hydrocarbon chains.[24] Plus, the main degradations of CMs and CCMs did not start at the same point; the thermographs showed different degradation behaviors for CMs and CCMs, which indicated that acid hydrolysis could have increased the degree of crystallinity and thus led to the different degradation behaviors.[25] With the increase of temperature, CMs and CCMs showed the degradation at the temperature range of 150–600 °C. The peak of DTGA represented the temperature of the maximum weight reduction. Based on the DTGA analysis, it can be observed that small degradation at 250 °C existed in CMs and then followed by a relatively small peak. Meanwhile, CCMs started the main decomposition at about 250 °C, and the degradation increased until the peak appeared, which suggested that CCMs possessed higher thermal stability than that of CMs. This result revealed the successful insertion of the carboxyl group on CMs.[20,25] CCMs can withstand the high temperature of autoclaving and sterilization before insulin loading, and the structure was not destroyed by the high temperature, so CCMs were suitable as insulin carriers.[26] To explore insulin loading and release mechanisms, the zeta potential of CCMs was measured from pH 1.0 to 13.0. The results are shown in Figure c. When pH > 2.3, the net negative zeta potential indicated that the ionization of carboxylic acid (COOHCOO–) increased the absolute value of the zeta potential, resulting in more negative charges.[24,27] The original pI of insulin fell in the range of 5.5–6.4,[19] and insulin showed a positive zeta potential at pH = 4 PBS. It indicated that insulin was loaded into CCMs by electrostatic action. When pH < 2.3, CCM dispersions showed a positive zeta potential, indicating the protonation of carboxylic acid. The hydrogen bonding interactions between the protonated carboxylic groups of CCMs might preserve the structure of CCMs in a compact collapsed state, preventing the release of insulin in AGF. However, insulin is negatively charged and CCMs are negatively charged in AIF. The electrostatic repulsion between COO– of CCM chains enlarged the pore size of CCMs and promoted water molecules into CCMs. At the same time, the electrostatic repulsion between insulin and CCMs also promoted the insulin diffusion and release. The esterification reaction among the CMs and citric acid can be verified by using the XPS technique too. Figure shows the peak spectra of C1s. The peaks at 284.8 and 286.3 eV belong to C–C and C–O–C, respectively.[28] Compared with Figure b, a new peak appeared at 288.6 eV in Figure c, which was attributed to the ester (O—C=O) peak.[29] In addition, the change of the peak (centered at 284.8 and 286.3 eV) area and the appearance of a new peak (O—C=O) (centered at 288.6 eV) in Figure c indicated the successful esterification reaction of hydroxyl groups on CMs with carboxyl groups of citric acid. This further showed the hydrolysis mechanism of citric acid/hydrochloric acid, which is also in accordance with the FT-IR results.[28,29]
Figure 3

XPS spectra of CMs and CCMs: C1s of CMs (a), C1s of CCMs (b), and survey of CMs and CCMs (c).

XPS spectra of CMs and CCMs: C1s of CMs (a), C1s of CCMs (b), and survey of CMs and CCMs (c).

Swelling Properties of CCMs

To examine the effect of solution pH on water uptake, the swelling ratio (SR) was determined using CCMs gravimetric ratios in AGF and AIF, respectively. The swelling property of CCMs was calculated with eq . CCMs showed higher swelling in AIF (598.3%) than in AGF (455.7%). This observation can be explained by the ionization and protonation equilibrium of the carboxyl groups (pKa = 4.3) in CCMs. In AGF, the carboxyl groups were protonated to promote the formation of intramolecular hydrogen bonds. Thereby, CCMs exhibited lower swelling ratios. While in AIF, the swelling ratios were higher than those in AGF. The reason was that the hydrogen bonds were broken in AIF and generated the electrostatic repulsion forces among the ionized carboxylic acids,[30,31] benefiting the diffusion of water molecules into CCMs, which therefore led to quick swelling. CCMs were responsive to changes in pH values, they can protect insulin against the gastric fluid in AGF while quickly swelling in AIF to facilitate the diffusion and absorption of insulin.

Insulin Loading and Controlled Release Performance of CCMs

To study the loading and releasing properties of insulin, a constant flow pump was used to simulate gastrointestinal absorption. CCMs were added in a glass column (internal diameter = 1.1 cm). The pH =4 insulin solution was used as eluent solution, which was collected after passing through the column with CCMs at predetermined time intervals to calculate insulin loading efficiency (ILE) and insulin loading quality (LC). The values of ILE and LC depended on the insulin concentration, insulin/CCMs ratio, solvent pH, etc.[30] The ILE and LC were observed as 2.6% and 335 mg g–1 via eqs and 5, respectively. This may be due to the opposite charges between insulin and CCMs at pH = 4. Insulin is positively charged at pH = 4[19] and CCMs are negatively charged at pH = 4 under room temperature as is shown by zeta potential of CCMs (Figure c), This promoted insulin loading via electrostatic interactions. To determine the release properties of insulin from insulin-CMs and insulinCCMs, the constant flow pump was used to simulate gastrointestinal absorption. AGF and AIF were used as eluent solutions, which were collected after passing through the column with CMs and CCMs at predetermined time intervals to obtain the breakthrough curves, respectively. The release behavior of insulin in AGF and AIF were studied, respectively (Figure ). As shown in Figure a, 68.44% of insulin were released in AGF, and 65.05% of insulin were released in AIF, respectively. The results showed that oral insulin delivery could not be controlled by CMs. Figure b shows the insulin release curves versus time from insulinCCMs in AGF and AIF, respectively. In AGF, 32.75% of insulin was released fast, followed by 17.05% of release. In AIF, the release rate was fast, with 44.5% of the total insulin release after 10 min, and then an equilibrium plateau was gradually established at about 85.3%. The burst release phenomenon was due to the fact that insulin was attached to the surface of CCMs.[32,33] Controlled release of insulin from insulinCCMs can be regulated by the proton balance of carboxyl groups and the charge of insulin in AGF and AIF. In AGF, the hydrogen bonding interactions between the protonated carboxylic groups of CCMs might preserve the structure of insulin in compact collapsed state, preventing the release of insulin.[13] In AIF, the carboxyl groups of CCMs existed as COO–. The electrostatic repulsion between COO– enlarged the pore size of CCMs and promoted water molecules into CCMs. Insulin, with a molecular weight of about 6000, is a hydrophilic water-soluble protein,[34] and it is also negatively charged in AIF. The electrostatic repulsion between insulin and CCMs also promoted the diffusion of insulin into water molecules. The insulin molecule contains six positively charged and 10 negatively charged amino acid residues. Due to a handful of positive charge in the insulin molecule and the formation of the hydrogel barrier after the CCM swelling, insulin was trapped in CCMs and could not be released completely. This indicated that the carboxyl groups of CCMs played an important role in the oral delivery of insulin.
Figure 4

Insulin release curves versus time from insulin–CMs in AGF and AIF, respectively (a); insulin release curves versus time from insulin–CCMs in AGF and AIF, respectively (b).

Insulin release curves versus time from insulinCMs in AGF and AIF, respectively (a); insulin release curves versus time from insulinCCMs in AGF and AIF, respectively (b). For the stomach and intestine environments, the calculated parameters of the Korsmeyer model are summed up in Table . The n values were less than 0.45; the correlation coefficients for the model ranged from 0.9397 to 0.9981, indicating that insulin was released according to the Fickian diffusion.
Table 1

Equilibrium Parameters of Korsmeyer Fitting Models

fluidknR2
AGF4.9600.06820.9981
AIF2.7050.19930.9397

Conformation of Insulin Release

The folding and conformation of insulin correlated with its activity and can change during the formulation process. Therefore, it is crucial to prepare controlled release systems that can release insulin in its active form. The qualitative and quantitative information about protein conformations were provided by CD spectra.[35] From Figure , the released insulin from insulinCCMs displayed similar characteristic peaks at about 208 and 223 nm on CD spectra compared with native insulin, suggesting that the secondary structure stability of released insulin was preserved during the loading and release processes. The CD results confirmed that there were no obvious conformational changes for the released insulin from insulinCCMs.
Figure 5

CD spectra of native insulin and released insulin from insulin–CCMs.

CD spectra of native insulin and released insulin from insulinCCMs.

In Vitro Cell Viability of Samples

Considering the safety of oral preparations, it is necessary to evaluate the toxicity of CMs and CCMs.[36] The cytotoxicities of CMs and CCMs were tested by the MTT method. The biocompatibility of CMs and CCMs was assessed by A549 cells (Figure. ). It can be seen from Figure that the viability of the cells was above 90%, indicating that both CMs and CCMs were noncytotoxic and had good biocompatibility. When the concentrations of CMs and CCMs reached 200 μg mL–1, the cell viability exceeded 100%. This suggested that high concentrations of cellulose-based microspheres promoted cell growth, which was indicative of low toxicity of cellulose microspheres.[37,38] Results showed that the CMs and the reagents used in the preparation of CCM carriers were nontoxic. CCMs have a potential application to safe oral insulin administration.
Figure 6

In vitro cell viability of A549 cells against CMs (a) and insulin–CCMs (b) with different concentrations.

In vitro cell viability of A549 cells against CMs (a) and insulinCCMs (b) with different concentrations.

Design Strategy and Insulin-Loaded and Controlled Release Mechanisms of CCMs

In this work, CCMs were used as the carrier to improve the oral bioavailability of insulin. The design mechanism of CCMs is depicted in Scheme . Based on the design principle of CCMs, the carboxyl group of citric acid was combined with the hydroxyl group of CMs through the esterification reaction so that CCMs is pH sensitive. The pI of insulin is 5.5–6.4, and the pI of the CCMs is 2.3. Insulin is positively charged and CCMs are negatively charged at pH = 4 PBS. Insulin was loaded into CCMs by electrostatic interactions. Scheme shows the controlled release mechanism of oral insulin from CCMs. The controlled release of insulin can be explained by the ionization and proton equilibrium of the carboxyl groups (pKa = 4.3) of CCMs. In AGF, pH = 1.2 PBS was lower than the pKa of the carboxyl groups, which made them positively charged. The carboxyl groups of CCM existed in the protonated form (−COOH). Hydrogen bond interactions between −COOH caused CCMs to shrink. CCMs were in a tight collapsed state, inhibiting the entry of water molecules and the diffusion of insulin. In AIF, pH = 7.4 PBS was higher than the pKa of the carboxyl groups, making them negatively charged. −COOH existed in the form of −COO–, and the electrostatic repulsion between −COO– caused the CCMs to swell. It was beneficial to the diffusion of water molecules into the CCMs and promoted the release of insulin. At the same time, the electrostatic repulsion between insulin and CCMs also promoted insulin diffusion and release.
Scheme 1

Synthesis of CCMs with the pH-Responsive Property and Controlled Release Mechanism of Insulin from CCMs

Conclusions

In this work, CCMs were prepared by a green route via the citric/hydrochloric acid hydrolysis method from CMs, which were prepared through the sol–gel transition method from green cellulose solvent. CCMs were chosen to be used as a candidate material of an oral insulin carrier. The oral bioavailability of insulin was insured by the pH sensitivity of CCMs. In vitro release studies demonstrated that release of insulin was 48.87 and 85.12% in AGF and AIF, respectively. The release curve of insulin from CCMs conformed to Fickian diffusion by the Korsmeyer–Peppas model fitting. The CD results that the secondary structure stabulity of released insulin was preserved during the loading and release process. Cell viability revealed that the CCMs were noncytotoxicity. These results indicated that the encapsulation of insulin into CCMs was a key factor in the improvement of its oral absorption and oral bioactivity; the designed CCMs had the potential for oral insulin delivery.

Materials and Methods

Materials

Cellulose (cotton linter pulp; α-cellulose > 95%) was purchased from Hubei Chemical Fiber Group Ltd. (Xiangfan, China). Its viscosity average molecular weight (Mv) was 12.5 × 104 Da. Citrate was purchased from Aladdin. Insulin (porcine pancreatic) was provided by Xuzhou WanBang Co. Phosphate buffer saline (PBS), AIF, (pH = 7.4 PBS), and AGF (pH = 1.2 PBS) were prepared to simulate the pH environment of the human stomach and intestines.[39] The pH = 1.2 PBS was prepared with 7 mL of hydrochloric acid (37 wt %) and 2.0 g of sodium chloride dissolved in 1 L of deionized water (DI water). Potassium dihydrogen phosphate (6.8 g) was dissolved in DI water, and the pH value was adjusted to 7.4, followed by diluting the solution to 500 mL to prepare pH = 7.4 PBS.

Preparation of CCMs

CMs were prepared through the sol–gel transition method according to our previous work.[40] CCMs were fabricated according to the citric/hydrochloric acid hydrolysis method.[20] Briefly, 8 g of CMs and the acid mixture (90% citric acid/10% hydrochloric acid (v/v)) were added to a 500 mL three-necked flask and stirred constantly (300 r min–1) at 80 °C for 4 h. After the reaction was completed, the suspension was quickly cooled to room temperature. Then, CCMs and mixed acids were separated by filtration processes, and CCMs were further washed three times with DI water to remove unreacted acid mixtures. Finally, CCMs were dried in a vacuum oven over at 60 °C for 48 h.

Characterizations

The morphology and structure of CMs, CCMs, and insulinCCMs were investigated by FE-SEM (GeminiSEM 300), and the surface elements were analyzed by EDS. Samples were crushed into powder for other characterizations, and pellets were pressed with potassium bromide for FT-IR analysis. FTIR spectra were recorded on an FT-IR spectrometer (170-SX, Thermo Nicolet Ltd., U.S.A.). The CMs and CCMs chemical states of the elements were measured by XPS (Kratos, U.K.). Thermal properties of the samples were assessed usingTGA instrument (STA449F3 Germany) under nitrogen atmosphere from 10 to 600 °C at rate of 10 °C min–1. The surface charge of the samples was determined by the Malvern nanoparticle size potentiometer (Zetasizer Nano S90). A secondary structure of insulin was evaluated by Chirascan Plus (Applied Photophysics, United Kingdom).

Graft Yield and Graft Efficiency of CCMs

The graft yield and graft efficiency of CCMs were calculated by the gravimetric method using the following relationships.where W0 is the CMs before reacting, Wg represents the weight of the CCMs after reacting, and Wm denotes the weight of the citric acid used for reacting.[41]

pH-Responsive Swelling

CCMs were immersed in AGF and AIF until the swelling equilibrium is reached to study the pH swelling properties of CCMs by the gravimetric method. Dry CCMs (Gi) (10 mg) were added to 50 mL of AGF and AIF soaking for 24 h, respectively. The immersing fluid was removed by centrifugation, and the weight of the wet CCMs (Gs) was recorded. The SR was calculated using the following equation:where Gs is the weight of wet CCMs, and Gi is the weight of dried CCMs.[26]

In Vitro Insulin Loading and Release Properties

Insulin was loaded into CCMs by electrostatic action. CCMs (0.4 g) were added in glass column (internal diameter = 1.1 cm). The column was pretreated with PBS eluent water of pH = 4. pH = 4 insulin solution was then used as the eluent solution. The eluent solution was collected after passing through the column with CCMs at predetermined time intervals to calculate the insulin loading efficiency and insulin loading quality. The concentration of insulin was detected by UV/vis spectrophotometer at wavelength of 276 nm and quantified by comparing with a standard curve.[42] When the concentrations (C) of insulin at pH = 4 PBS were 0.0, 0.2, 0.4, 0.6, 0.8, and 1.0 mg mL–1, the absorbance (A) at the wavelength of 276 nm were 0.000, 0.212, 0.395, 0.620, 0.820, and 1.046, respectively. Then the standard curve equation A = – 0.004 + 1.040C (R2 = 0.999) was obtained by linear fitting. Finally, the concentration of insulin was calculated according to the standard curve equation. ILE (%) and LC(mg g–1) were calculated using the following equations:where C0 and C1 are the initial insulin concentration (mg mL–1) and the final or equilibrium insulin concentration (mg mL–1), respectively. V represents the volume of insulin solution (mL), and m denotes the dry weight of CCMs (g). In order to assess the insulin release property, constant flow pump was used to simulate gastrointestinal absorption. AGF and AIF were used as eluent solutions, which were collected after passing through the column with CCMs at predetermined time intervals to obtain the breakthrough curves, respectively. The concentration of insulin was calculated according to the standard curve equation. The cumulative release percentage of insulin was calculated according to the equation as follows:[13]where m represents the mass of insulin in insulinCCMs before release, V denotes the volume of the eluted water in the collector at a predetermined time interval, and C means the concentration of insulin in the nth predetermined time interval. The insulin release data were fitted by the Korsmeyer–Peppas equation to study the kinetics of insulin release from insulin-CCMs:[43] Here, M is the mass of insulin released from the start of release to time t, M∞ means the mass of insulin in insulinCCMs before release, and K and n denotes the rate constant and release exponent, respectively. The mechanism of insulin release depends on the value of n: n ≤ 0.45 indicates the Fickian diffusion model, 0.45 < n < 0.89 corresponds to the non-Fickian diffusion model, and n > 0.89 corresponds to the case II diffusion model.

Cytotoxicity of CCMs and Insulin–CCMs

To evaluate the potential toxicity of CMs and CCMs, the MTT assay was performed to measure the cell cytotoxicity of CMs and CCMs in A549 cells.[44,45] The A549 cells were seeded into a 96-well plate for 24 h, and then CMs and CCMs with a concentration gradient (0, 50, 100, 150, and 200 μg mL–1) were added to the culture medium and cultured at 37 °C for 24 h. After removing the culture medium, 3-(4, 5-dimethylthiazol-2-yl)-3,5-diphenyltetrazolium bromide (MTT) solution was added to A549 cells and cultured for 4 h. Then, 200 μL of DMSO was added to the A549 cells after the removal of the MTT solution. The crystals were sufficiently dissolved by low-speed shaking. The absorbance was measured at 495 nm with microplate reader (SpectraMax M5, Molecular Devices).[46,47]

Circular Dichroism (CD) Tests of Released Insulin

The activity of released insulin was evaluated by analysis of the structural stability by using CD spectrophotometer according to Hong et al.[48] The released insulin and native insulin were measured at 25 °C with a cell path length of 1.0 cm, a bandwidth of 1.0 nm, response time of 0.25 s, and constant nitrogen flow of 5 L min–1. The native insulin was prepared in pH = 7.4 PBS. The samples were scanned from 190 to 250 nm at resolution of 1.0 nm. For CD tests, each sample was tested for three times, and the final data took the average of three measurements.
  37 in total

Review 1.  Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.

Authors:  Chun Y Wong; Hani Al-Salami; Crispin R Dass
Journal:  J Control Release       Date:  2017-09-05       Impact factor: 9.776

2.  Visible-Light-Activated High-Density Materials for Controlled in Vivo Insulin Release.

Authors:  Bhagyesh R Sarode; Karen Kover; Simon H Friedman
Journal:  Mol Pharm       Date:  2019-10-24       Impact factor: 4.939

3.  Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.

Authors:  Kevin Ling; Huixia Wu; Andrew S Neish; Julie A Champion
Journal:  J Control Release       Date:  2018-12-14       Impact factor: 9.776

4.  Dual Stimuli-Responsive Nanoparticle-Incorporated Hydrogels as an Oral Insulin Carrier for Intestine-Targeted Delivery and Enhanced Paracellular Permeation.

Authors:  Liang Liu; Ying Zhang; Shuangjiang Yu; Zhiming Yang; Chaoliang He; Xuesi Chen
Journal:  ACS Biomater Sci Eng       Date:  2018-07-17

5.  Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies.

Authors:  Elisabetta Muntoni; Elisabetta Marini; Nahid Ahmadi; Paola Milla; Corrado Ghè; Alessandro Bargoni; Maria Teresa Capucchio; Elena Biasibetti; Luigi Battaglia
Journal:  Acta Diabetol       Date:  2019-08-12       Impact factor: 4.280

6.  Nanochaperones Mediated Delivery of Insulin.

Authors:  Chang Li; Xiaoyu Liu; Yanli Zhang; Juan Lv; Fan Huang; Gang Wu; Ying Liu; Rujiang Ma; Yingli An; Linqi Shi
Journal:  Nano Lett       Date:  2020-02-21       Impact factor: 11.189

7.  Poly(ester amide) blend microspheres for oral insulin delivery.

Authors:  Pan He; Huaiyu Liu; Zhaohui Tang; Mingxiao Deng; Yan Yang; Xuan Pang; Xuesi Chen
Journal:  Int J Pharm       Date:  2013-07-19       Impact factor: 5.875

8.  Development of pH Sensitive Alginate/Gum Tragacanth Based Hydrogels for Oral Insulin Delivery.

Authors:  Sevil Cikrikci; Behic Mert; Mecit Halil Oztop
Journal:  J Agric Food Chem       Date:  2018-10-30       Impact factor: 5.279

Review 9.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Formulation, physicochemical characterization and in vitro evaluation of human insulin-loaded microspheres as potential oral carrier.

Authors:  Gauravkumar R Agrawal; Pravin Wakte; Santosh Shelke
Journal:  Prog Biomater       Date:  2017-09-01
View more
  1 in total

Review 1.  Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures.

Authors:  Mengjie Wang; Chunxin Wang; Shuaikai Ren; Junqian Pan; Yan Wang; Yue Shen; Zhanghua Zeng; Haixin Cui; Xiang Zhao
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.